Emile Ferrari

Summary

Country: France

Publications

  1. ncbi request reprint [Cardiotoxicity associated with trastuzumab (herceptin). An undesired effect leads towards a model of cardiac insufficiency]
    E Ferrari
    Service de cardiologie, Nice
    Arch Mal Coeur Vaiss 97:333-7. 2004
  2. ncbi request reprint Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment
    Emile Ferrari
    Cardiology Department, Pasteur University Hospital, 30 Ave de la Voie Romaine, Nice 06002, France
    Chest 127:1051-3. 2005
  3. ncbi request reprint Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis
    Emile Ferrari
    Cardiology Department, Pasteur Hospital, 30 Avenue de la Voie Romaine, Nice, Alpes Maritimes 06200, France
    J Am Coll Cardiol 45:456-9. 2005
  4. ncbi request reprint [Impact of biochemisty on the duration of treatment for pulmonary embolus]
    E Ferrari
    Service de cardiologie, Hopital Pasteur, Nice
    Arch Mal Coeur Vaiss 96:1198-201. 2003
  5. doi request reprint B blood group: A strong risk factor for venous thromboembolism recurrence
    Delphine Baudouy
    Cardiology Department, Pasteur University Hospital, CHU de Nice, France
    Thromb Res 136:107-11. 2015
  6. doi request reprint Speckle-tracking imaging in patients with Eisenmenger syndrome
    Pamela Moceri
    Cardiology Department, Hopital Pasteur, CHU de Nice, 06002 Nice, France Faculté de Médecine, Universite de Nice Sophia Antipolis, 06002 Nice, France Electronic address
    Arch Cardiovasc Dis 109:104-12. 2016
  7. doi request reprint Timing of troponin I measurement in pulmonary embolism
    Emile Ferrari
    Department of Cardiology, University Hospital of Nice, 30 Avenue de la Voie Romaine, Nice 06002, France
    Heart 98:732-5. 2012
  8. ncbi request reprint Penetrating atherosclerotic ulcers of the infrarenal aorta: life-threatening lesions
    M Batt
    Department of Vascular Surgery, Hopital Saint Roch, 0600 Nice Cedex 1, France
    Eur J Vasc Endovasc Surg 29:35-42. 2005
  9. ncbi request reprint [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties]
    E Ferrari
    Service de cardiologie, , CHU, 30, avenue de la Voie Romaine, 06002 Nice
    Arch Mal Coeur Vaiss 94:1301-6. 2001
  10. doi request reprint Real time three-dimensional echocardiographic assessment of left ventricular function in heart failure patients: underestimation of left ventricular volume increases with the degree of dilatation
    Pamela Moceri
    Cardiology Department, University Hospital of Nice, Nice, France
    Echocardiography 29:970-7. 2012

Collaborators

Detail Information

Publications19

  1. ncbi request reprint [Cardiotoxicity associated with trastuzumab (herceptin). An undesired effect leads towards a model of cardiac insufficiency]
    E Ferrari
    Service de cardiologie, Nice
    Arch Mal Coeur Vaiss 97:333-7. 2004
    ..These studies not only explain all the clinical signs of Trastuzumab's cardiotoxicity but also suggest ways of preventing and treating some of these cases of cardiac failure...
  2. ncbi request reprint Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment
    Emile Ferrari
    Cardiology Department, Pasteur University Hospital, 30 Ave de la Voie Romaine, Nice 06002, France
    Chest 127:1051-3. 2005
    ..How these clots evolve after treatment, in particular after thrombolytic treatment (TT), is unknown. We sought to determine the outcome of these mobile clots in the RH during TT...
  3. ncbi request reprint Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis
    Emile Ferrari
    Cardiology Department, Pasteur Hospital, 30 Avenue de la Voie Romaine, Nice, Alpes Maritimes 06200, France
    J Am Coll Cardiol 45:456-9. 2005
    ..We sought to determine whether aspirin withdrawal is an encountered situation in coronary disease patients who relapsed...
  4. ncbi request reprint [Impact of biochemisty on the duration of treatment for pulmonary embolus]
    E Ferrari
    Service de cardiologie, Hopital Pasteur, Nice
    Arch Mal Coeur Vaiss 96:1198-201. 2003
    ..The first results of this approach are interesting, but require confirmation before they can be used in practice...
  5. doi request reprint B blood group: A strong risk factor for venous thromboembolism recurrence
    Delphine Baudouy
    Cardiology Department, Pasteur University Hospital, CHU de Nice, France
    Thromb Res 136:107-11. 2015
    ..However, only little is known about the risk of recurrence according to the blood group. In this study, we aimed to determine the impact of ABO blood group on VTE recurrence...
  6. doi request reprint Speckle-tracking imaging in patients with Eisenmenger syndrome
    Pamela Moceri
    Cardiology Department, Hopital Pasteur, CHU de Nice, 06002 Nice, France Faculté de Médecine, Universite de Nice Sophia Antipolis, 06002 Nice, France Electronic address
    Arch Cardiovasc Dis 109:104-12. 2016
    ..Adults with Eisenmenger syndrome have a survival advantage over those with idiopathic pulmonary arterial hypertension. Improved survival may result from preservation of right ventricular (RV) function...
  7. doi request reprint Timing of troponin I measurement in pulmonary embolism
    Emile Ferrari
    Department of Cardiology, University Hospital of Nice, 30 Avenue de la Voie Romaine, Nice 06002, France
    Heart 98:732-5. 2012
    ..Troponin I (TnI) is an important prognostic marker and risk-stratification tool in patients with pulmonary embolism (PE). However, the best timing for this biomarker measurement is still unclear...
  8. ncbi request reprint Penetrating atherosclerotic ulcers of the infrarenal aorta: life-threatening lesions
    M Batt
    Department of Vascular Surgery, Hopital Saint Roch, 0600 Nice Cedex 1, France
    Eur J Vasc Endovasc Surg 29:35-42. 2005
    ..To analyze the incidence, clinical features, natural history, and treatment of penetrating atherosclerotic ulcers (PAU) of the abdominal aorta...
  9. ncbi request reprint [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties]
    E Ferrari
    Service de cardiologie, , CHU, 30, avenue de la Voie Romaine, 06002 Nice
    Arch Mal Coeur Vaiss 94:1301-6. 2001
    ..The results of studies evaluating the durations of long-term treatment with less intense levels of anticoagulation (INR < 2) as well as therapeutic alternatives to antivitamin K (antiaggregants or other antithrombins) are awaited...
  10. doi request reprint Real time three-dimensional echocardiographic assessment of left ventricular function in heart failure patients: underestimation of left ventricular volume increases with the degree of dilatation
    Pamela Moceri
    Cardiology Department, University Hospital of Nice, Nice, France
    Echocardiography 29:970-7. 2012
    ....
  11. ncbi request reprint Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants
    E Ferrari
    Cardiology Department, Hopital Pasteur, Nice, France
    J Am Coll Cardiol 33:1317-22. 1999
    ....
  12. doi request reprint Imaging in pulmonary hypertension: Focus on the role of echocardiography
    Pamela Moceri
    Service de cardiologie, Hopital Pasteur, CHU de Nice, 30, avenue de la Voie Romaine, BP69, CS 51069, 06001 Nice Cedex 1, France Electronic address
    Arch Cardiovasc Dis 107:261-71. 2014
    ..In this review, we will link pulmonary hypertension pathophysiological changes with echocardiographical indices and describe the clinical implications of echocardiographical findings...
  13. ncbi request reprint [Duration of antivitamin K therapy in venous thromboembolic disease]
    E Ferrari
    Service de cardiologie, CHU, Nice
    Arch Mal Coeur Vaiss 88:1891-4. 1995
    ..The evaluation of longer treatment protocols with less intensive degrees of anticoagulation and of alternatives to oral vitamin K antagonists is justified...
  14. doi request reprint From adolescents to adults with congenital heart disease: the role of transition
    Pamela Moceri
    Cardiology Department, Pasteur University Hospital, Nice, France
    Eur J Pediatr 174:847-54. 2015
    ..The aim of this review is to explain and discuss the clinical impact of the transition process in adolescents with CHD. We will also discuss specific CHD adolescents' problems...
  15. doi request reprint Doubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazole
    Pamela Moceri
    Cardiology Department, Pasteur Hospital, CHU de Nice, Nice, France
    Thromb Res 128:458-62. 2011
    ..We studied the impact of esomeprazole and ranitidine on the antiplatelet action of clopidogrel and aspirin and sought to determine whether doubling the dose of clopidogrel could restore its efficacy...
  16. ncbi request reprint [The best of thrombosis and thromboembolic disease in 1999]
    E Ferrari
    Service de cardiologie, , Nice
    Arch Mal Coeur Vaiss 93:77-81. 2000
    ..This emphasises the importance of early diagnosis which is usually possible without resorting to invasive procedures and by modulating all the results of paraclinical investigations with respect to the pretest clinical probability...
  17. ncbi request reprint [Venous thromboembolism and cancer]
    E Ferrari
    , CHU, Service de cardiologie, 30, avenue de la Voie Romaine, 06002 Nice
    Arch Mal Coeur Vaiss 94:1307-12. 2001
    ..Moreover, some publications have demonstrated a chance finding of a possible anticancer effect of antithrombotic agents...
  18. ncbi request reprint [Epidemiology of pulmonary embolism]
    E Ferrari
    Service de cardiologie, , Nice
    Arch Mal Coeur Vaiss 88:1687-91. 1995
    ..Further progress could come from improved identification of patients at risk, especially by biological tests and new abnormalities of blood coagulation...
  19. ncbi request reprint Travel as a risk factor for venous thromboembolic disease
    Emile Ferrari
    Department of Cardiology, University Hospital Pasteur, 30 Avenue de la Voie Romaine, Nice, France
    Eur J Med Res 9:146-9. 2004
    ..A 100 AXa U/kg single dose of a low molecular weight heparin, given 2-4 hours before the flight, have been reported to be more effective than aspirin and placebo. However, the benefit/risk ratio of such a strategy remains to be assessed...